Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.
about
A kernelisation approach for multiple d-Hitting Set and its application in optimal multi-drug therapeutic combinationsPrediction of survival for advanced cancer patients by recursive partitioning analysis: role of Karnofsky performance status, quality of life, and symptom distress.Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.Carboplatin, etoposide, and accelerated hyperfractionated radiotherapy for elderly patients with limited small cell lung carcinoma: a phase II study.Metabolic burden measured by (18)f-fluorodeoxyglucose positron emission tomography/computed tomography is a prognostic factor in patients with small cell lung cancerPrognostic factors for limited-stage small cell lung cancer: a study of 284 patients.The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer.Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission.Temporal trends from 1986 to 2008 in overall survival of small cell lung cancer patients.Common arm comparative outcomes analysis of phase 3 trials of cisplatin + irinotecan versus cisplatin + etoposide in extensive stage small cell lung cancer: final patient-level results from Japan Clinical Oncology Group 9511 and Southwest Oncology GA retrospective study of risk and prognostic factors in relation to lower respiratory tract infection in elderly lung cancer patients.Tumor volume and patient weight as predictors of outcome in children with intermediate risk rhabdomyosarcoma: a report from the Children's Oncology Group.Lung cancer 7: management of lung cancer in elderly patients.Limited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms.Long term survival of small cell lung cancer patients after chemotherapy.'Tumour volume' as a predictor of survival after resection of non-small-cell lung cancer (NSCLC)Efficacy and safety of angiogenesis inhibitors in small-cell lung cancerEndobronchial mucosa invasion predicts survival in patients with small cell lung cancer.Outpatient treatment with epirubicin and oral etoposide in patients with small-cell lung cancer.Time and chemotherapy treatment trends in the treatment of elderly patients (age >/=70 years) with small cell lung cancer.Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994Benefit from thoracic radiotherapy in patients with extensive-disease small-cell lung cancer with elevated lactate dehydrogenase.c-Met Mutational Analysis in the Sema and Juxtamembrane Domains in Small-Cell-Lung-Cancer.Survival from lung cancer in England and Wales up to 2001Lung cancer and women.Racial and Ethnic Differences in the Epidemiology and Genomics of Lung Cancer.Palliative care in poor-performance status small cell lung cancer patients: is there a mandatory role for chemotherapy?MET and Small-Cell Lung Cancer.Prognostic significance of serum lactate dehydrogenase levels in Ewing's sarcoma: A meta-analysis.Prognostic role of patient gender in limited-disease small-cell lung cancer treated with chemoradiotherapy.Cumulative Intracranial Tumor Volume (CITV) Enhances the Prognostic Value of the Lung-Specific Graded Prognostic Assessment (GPA) Model.An analysis of the outcomes of treatment of small cell lung cancer in the elderly.Evaluation of factors associated with platinum-sensitivity status and survival in limited-stage small cell lung cancer patients treated with chemoradiotherapy.Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years.Anemia as an independent prognostic factor for survival in patients with cancer.The role of surgery in high grade neuroendocrine tumours of the lung.High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer.New insights into stage and prognosis in small cell lung cancer: an analysis of 968 cases.Prognostic factors and survival of patients with small cell lung cancer in a northeastern Chinese population.
P2860
Q28475822-D66F9ED4-CBAD-4A84-A5A2-95FB92140E12Q33209607-174003F6-848C-42CE-96C7-24B024FD456FQ33384024-F9B0BE57-458A-4871-85D9-7A5DF36EC14DQ33436297-52DAE3EE-7ABA-46D6-AC6C-F96CD7F1765AQ33501796-994C4757-F654-4571-995C-A5F46975A5DBQ33619243-1B98D96A-E89C-4436-B611-581AFB6E90D1Q33625372-0A00DE6A-D420-4CB0-B3D0-6EC8B4303B25Q33994372-78F3B823-D4A1-49B2-B1E4-059FF4650E7BQ34062440-7B0004BD-60A4-4D28-8731-41CB264B1CCEQ34226656-D6414036-9285-402B-AC2D-DA63847FF194Q34367343-A79774DA-F689-4F96-AC28-D7B1616721E0Q34991328-013DC658-3821-41AE-9C61-EA9A7CEEC820Q35051029-754E2CF1-2ADC-4739-B859-2BA6BBCE89B6Q35186819-2BC51F3A-17B7-434A-AA52-DD93DE79D82AQ35583915-5070FF37-5399-4B1D-AC3F-F16452E87412Q35976489-14CC4D78-FB3D-4FEB-8131-55D979F7F4E1Q36135776-EBDAA842-56FD-42D5-87AB-F3CC9304CBAEQ36207730-D3745952-4BD4-429E-8FF3-D91A56800B7BQ36297434-CE22FA2A-1261-4012-B144-1A76E7FA4573Q36430993-92F1A5A6-98B0-4D91-9B23-4D6D159DD1D4Q36613507-88BB3CC3-BD62-400E-BAC6-CDE8727E7ECFQ36643410-5E88139D-FF14-4C64-B28F-34D81035BAD9Q36657575-B8BF7C51-51FF-4E7B-9FBB-8342178D948EQ36812161-9C328A81-E30A-47D8-94A3-4213EF3CA2FAQ36917779-B8700585-A6DA-4E22-8697-F64C764482BCQ37298672-6A6558F8-FED8-4A78-947C-DD7C1731CB9EQ37684483-174FEE35-5315-4C05-A351-59F1F038A73AQ37982977-C11B5C82-0988-4758-B028-F22EB4A72C76Q38260120-80895069-B0BC-4997-9FF0-FA593FAC120FQ39095969-6E9A3D6D-393E-40FF-8809-D6EC897797CDQ39181700-50EDBDE7-6480-41FE-A955-D05A53B358B6Q40308840-D4E14721-CADF-4624-9CCD-AC0BA7DDF528Q41465938-9E18E325-71FE-485D-A5F2-C4C1ECA9EE89Q43139088-D934609A-D6E2-490F-AD6C-E92225F979FEQ43517625-D8E756B4-788E-4200-8F4A-FE03F97CDBDDQ43680780-E574E4B1-B47F-4590-9473-2815043B1E8BQ47117731-6CB29D38-754C-4655-89B9-32C74FE9E510Q47119500-4A2D36D9-B1EB-4B15-90AF-EF0A9281FB0DQ47556514-50789D1A-4564-4417-A1B1-5DD9512FF0A3Q50050610-E8B5FAB1-DDD2-47A3-B465-43EB3965CF78
P2860
Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.
description
1990 nî lūn-bûn
@nan
1990 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Determinants of improved outco ...... west Oncology Group data base.
@ast
Determinants of improved outco ...... west Oncology Group data base.
@en
type
label
Determinants of improved outco ...... west Oncology Group data base.
@ast
Determinants of improved outco ...... west Oncology Group data base.
@en
prefLabel
Determinants of improved outco ...... west Oncology Group data base.
@ast
Determinants of improved outco ...... west Oncology Group data base.
@en
P2093
P1476
Determinants of improved outco ...... west Oncology Group data base.
@en
P2093
J J Crowley
K S Albain
R B Livingston
P304
P356
10.1200/JCO.1990.8.9.1563
P407
P577
1990-09-01T00:00:00Z